Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 7:12 PM View:  | Viridian Therapeutics, Inc.... (VRDN) | 27-Sep-24 | Market Purchase | 5,000 | $23.41 | $117,050.00 | 500% 1.0K to 6.0K | (2%) |
| 02-Dec-22 4:26 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 30-Nov-22 | Grant | 3,000 | $0.94 | $2,820.00 | 18% 16.9K to 19.9K | |
| 06-Jun-22 4:05 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 31-May-22 | Grant | 3,000 | $0.99 | $2,970.00 | 22% 13.9K to 16.9K | |
| 20-Sep-21 5:00 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 16-Sep-21 | Market Sale | 6,103 | $6.73 | $41,073.20 | (31%) 20.0K to 13.9K | (16%) |
| 16-Sep-21 7:39 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 14-Sep-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 05-Feb-21 6:55 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 03-Feb-21 | Conversion | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 05-Feb-21 6:55 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 03-Feb-21 | Market Sale (Planned) | 2,477 | $22.09 | $54,716.90 | (< 1%) 300.0K to 297.52K | |
| 02-Jul-20 4:13 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Jul-20 | Market Sale (Planned) | 29,589 | $25.37 | $750,678.00 | (100%) 29.59K to 0 | |
| 12-Jun-20 5:50 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 10-Jun-20 | Option Exercise | 13,752 | $1.59 | $21,865.70 | 46% 29.59K to 43.34K | |
| 12-Jun-20 5:50 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 10-Jun-20 | Market Option Sale (Planned) | 13,752 | $25.07 | $344,763.00 | (32%) 43.34K to 29.59K | |
| 22-Apr-20 5:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 21-Apr-20 | Market Sale (Planned) | 2,518 | $19.89 | $50,092.50 | (8%) 32.11K to 29.59K | |
| 22-Apr-20 5:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 20-Apr-20 | Market Sale (Planned) | 47,423 | $19.06 | $903,882.00 | (60%) 79.53K to 32.11K | |
| 19-Feb-20 5:24 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 14-Feb-20 | Market Sale (Planned) | 59 | $18.58 | $1,096.22 | (< 1%) 79.59K to 79.53K | |
| 29-May-18 7:20 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 29-May-18 | Conversion | 6,392 | -- | -- | 9% 73.2K to 79.59K |